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Abstract: 
Background: Disclosure of  HIV status is important for optimal adherence to antiretroviral therapy in children. Identifying 
factors that affect disclosure of  sero-status to children will help improve the process of  disclosure. The purpose of  the study 
was to determine the rate of  HIV disclosure by the parents/caretakers to their children and other factors affecting disclosure. 
Methods: A cross sectional study among 174 caretakers of  children age 5-18 years, twenty children and all (ten) health 
workers at Jinja Hospital paediatric HIV clinic. Data was collected with standardized questionnaires on socio-demographic 
factors, disclosure status, health facility factors, fears and perceived benefits of  disclosure. 
Results: We found disclosure rates in 56% of  the children. Among those not disclosed to, non-disclosure was 19% and 
deception 25%. Factors associated with disclosure of  sero-status to a child were age of  child (X2 37.4 df  1 p< 0.001), child 
being on antiretroviral therapy (OR 2.0 CI 1.1-3.6 p=0.024) and child attending psychosocial support group (OR 7.4 CI 
3.6-15.3 p < 0.001). There were no appropriate guidelines on disclosure and only half  of  health providers had training on 
disclosure of  HIV serostatus to children. 
Conclusion: The overall prevalence of  disclosure was low. Psychosocial support groups promoted disclosure.
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Introduction
The Joint United Nations Programme on HIV and 
AIDS (UNAIDS)1 estimates that 260 000 children be-
came newly infected with HIV worldwide by end of  
2012.UNICEF2 estimates that about 190,000 children 
aged 0-14 years in Uganda are infected with HIV. Ac-
cording to Ministry of   Health (MOH), of   the 130,000 
new infections that occur, about 18% is through moth-
er to child transmission of  HIV (MTCT).3  The avail-
ability of  HIV counseling, testing, and treatment with 
Antiretroviral Treatment (ART) during pregnancy has 
led to a dramatic drop in the rate of  perinatal trans-
mission, as well as significantly improved morbidity and 
mortality.4 With increased survival, parents and caregiv-
ers of  perinatally HIV infected children face the chal-
lenge of  disclosure of  HIV serostatus to their infected 
children.5 Benefits of  disclosure include good adher-
ence,6 improved healthcare and better dialogue among 
the adolescents, caregivers, and healthcare providers.7 
The challenges of  disclosure include concerns that the 
child might be psychologically harmed or may not keep 
the secret8 and fear that the stigma of  AIDS will have 
a negative impact on their children and families Wein-
er et al.9 Although sub Saharan Africa has one of  the 
highest numbers of  children with HIV, disclosure of  
HIV status to infected children has received relatively 
little attention.10 With a high burden of  HIV in chil-
dren, disclosure is an issue that families, practitioners, 
and researchers need to address.5 As an increasing num-
ber of  children born infected with HIV live to older 
ages, the question of  when and how to talk with them 
about their HIV status becomes more crucial. Despite 
the benefits of  disclosure, many parents/caretakers do 
not disclose to the children.11,12,13 There are few studies 
describing the development and evaluation of  interven-
tions to facilitate disclosure.5
In the MOH guidelines for HIV counseling and test-
ing, it is stated that disclosure should be done at the 
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guidelines recommend that counselors should aim at 
disclosing the status of  children by 10 years,14 and yet 
there are no guidelines on how this should be achieved. 
World Health Organization recommends that children 
of  school age should be told their HIV positive status 
but the specific age appropriate counselling advise for 
health workers and child's parents/caregivers are not 
provided.15 In Jinja Hospital, efforts have been made 
to encourage caretakers to disclose to children by on-
going counseling and establishing psychosocial support 
groups. This study explored factors affecting disclosure, 
its consequences and prevalence of  disclosure. Identi-
fying factors that affect disclosure of  sero status in chil-
dren will help improve disclosure by assisting caregivers 
and children deal with this difficult process. 
Prevalence and patterns of  disclosure
Disclosure of  HIV serostatus is when the child is giv-
en information about their illness (HIV and/or AIDS). 
There are various patterns of  disclosure, ranging from 
non-disclosure, partial disclosure to full disclosure. Al-
though complete nondisclosure (no mention of  HIV 
or of  any illness) does take place,  in the child’s early 
years, partial disclosure is more common. Partial dis-
closure16 is the term used for describing situations in 
which children are given some but not all information 
about their illness. When full disclosure occurs, children 
are told the name of  the illness (HIV and/or AIDS), 
disease specific information, and how they acquired the 
disease.  The rates of  disclosure ranged from a low  of  
17 to 70% as reported in several studies,4,8,17,18,19,20,21,22,23,24 
non-disclosure 23%  and deception 20% particularly in 
young children.17 Partial disclosure was reported to vary 
between 35-40% by Gortmarker et al,4 and Weiner et 
al.9 Partial disclosure often occurs in conjunction with 
illness deception.4
There is controversy about the age of  disclosure with 
some people advocating for disclosure as early as 5-7 
years.8,23 Age has been reported to be the most impor-
tant predictor of  whether or not the child is disclosed 
to.8,9
Methodology
Study setting: The study was conducted at Jinja Re-
gional Referral Hospital Paediatric HIV clinic.
Study design: This was a cross sectional study.
Sampling and procedure: Recruitment was by con-
secutive enrolment. Sample size was calculated using 
the formula developed by Kish and Leslie26, 1965 and 
using 67% as the proportion of  children who had been 
disclosed to.6 Written informed consent was obtained 
from caretakers. The interview was conducted by the 
principal investigator using a questionnaire. Inclusion 
criteria was primary caretakers (parent or guardian who 
provides majority of  child's ongoing daily care) of  chil-
dren with HIV aged 5 to 18 years. Exclusion criteria 
was if  the caretaker was not able to give all the required 
information especially with regards to disclosure. The 
dependent variable was disclosure of  HIV sero status 
to the child. The independent variables were child re-
lated factors including socio demographic factors like 
age, sex and level of  education of  the child, primary 
caretaker factors like socio-demographic factors and re-
lationship with the child. Health facility service factors 
including type of  pre and post test counseling, psycho-
social support groups, ongoing counseling and health 
service provider factors. Other independent variables 
included perceived benefits, reasons for disclosure, 
fears and problems encountered, right person to dis-
close and health facility factors.
Children and health workers were interviewed to sup-
plement what caretakers reported. Assent from children 
above 10 years old whose caretakers had consented and 
to whom HIV serostatus was disclosed and caretaker 
thought the child could discuss issues of  HIV.  They 
were interviewed using a simplified semi-structured 
questionnaire to assess the level of  understanding of  
the disease and disclosure. To avoid inadvertent disclo-
sure, caregivers were required to confirm the child’s dis-
closure status before the interview. Health care workers 
in the paediatric HIV clinic were interviewed using an 
interviewer administered questionnaire  to explore their 
opinions, experiences and attitudes regarding paediatric 
HIV disclosure, training on disclosure to children, ex-
istence and need for guidelines. The data was entered 
using EPIINFO and analysed using the SPSS version 
12.0.1. To assess prevalence of  disclosure, results ob-
tained for prevalence were expressed as a percentage 
(the number of  patients disclosed to was the numer-
ator and total number enrolled was the denominator). 
Data was summarized using frequency tables for cate-
gorical data. Means and standard deviation were used 
to summarize continuous variables. Confidence interval 
of  95% was obtained and Chi-squared test was used to 
ascertain statistical significance of  association between 
categorical variables and disclosure. Odd’s ratio was 
used to determine the relative risk. P-values of  below 
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0.05 were considered significant. Predictors of  disclo-
sure were determined using binary logistic regression 
analysis. Variables significantly associated with disclo-
sure in the bivariate analysis were entered into the sub-
sequent multivariate logistic regression models with 
disclosure as the dependent variable. Thematic analytic 
approach was used to analyse the responses to the an-
swers by the health service providers.
Ethical clearance: Approval was obtained from Mak-
erere University School of  Public Health Higher De-
grees Research and Ethics committee and Uganda Na-
tional Council for Science and Technology. Permission 
was obtained from Jinja Hospital 
Limitations: The study involved obtaining self  report-
ed information from respondents so there might have 
been bias in reporting by the caretaker especially with 
regards to disclosure status. We overcame this by asking 
probe questions to increase rigour. 
Results
Profiles of  the study sample
Between March and June 2009, interviews were con-
ducted for 174 primary caretakers of  children attend-
ing Jinja Hospital Paediatric HIV clinic and 20 children 
who had been disclosed to and whose primary caretaker 
had consented and thought the child was able to discuss 
issues related to HIV.  Ten health workers were also in-
terviewed. Results for the three groups interviewed are 
presented together. Mean age of  the children was 9.9 
years (sd ±3.3), median 9 years and range was 5 to 18 
years. Eighty three (47.7%) of  the children were male. 
Eighty three (47.7%) of  the caretakers were male. Only 
21.3% and 11.5% had achieved tertiary and no educa-
tion respectively. Considering relation of  the caretaker 
to the child, 36% was mother, 15.5% was father and 
another 15.5% was both. Only 28% of  caretakers were 
salaried employees, 24% subsistence farmers and 35% 
were in petty business.  
Prevalence and patterns of  disclosure
Table 1 shows prevalence and patterns of  disclosure. 
The patterns of  disclosure were initially categorized as 
disclosed to and not disclosed to.  This was further dis-
aggregated into complete, partial disclosure, complete 
non-disclosure and deception. We found disclosure 
rates in 56% of  the children. Among those not dis-
closed to, non-disclosure was 19% and deception 25%. 
For the younger children, caretakers said that much as 
they had been told that they had HIV, they did not seem 
to understand the illness well. Among children not dis-
closed to, 19% had been told nothing related to HIV/
AIDS and about 25% overall had been told lies (table 
1). In the group that had been told lies, care takers pre-
ferred to use non- stigmatizing chronic and/or co-mor-
bid illnesses like asthma, tuberculosis, sickle cell or skin 
disease.
Table 1: Prevalence and patterns of disclosure 
 
Type of Disclosure Number (%) Patterns of disclosure 
within disclosure category 
Number (%) 
Disclosed to  98 (56.3%) Complete disclosure  75 (43.1%) 
  Partial disclosure  23 (13.2%) 
Not disclosed to  76 (43.7%) Complete non-disclosure  33 (19%) 
  Deception  43 (24.7%) 
 
Bivariate analysis of  factors associated with disclosure
Bivariate analysis of  the child related factors was done 
and the results are presented in table 2. There is a sta-
tistically significant relationship between disclosure of  
HIV serostatus to children and age of  the child ( Chi 
Square 37.4 with 2 df  .  p<0.000 (Table 2). Disclosure is 
not distributed similarly across the different age groups 
(the older children are likely to be disclosed to). Sixty 
eight percent of  the children were attending the psycho 
social support group and they were seven times more 
likely to be disclosed to (Table 2).
About 58% of  the children were on ART. A child on 
ART was twice as likely to be disclosed to (p=0.024). 
When the duration on ART was considered, those who 
had been on ART for more than 12 months were more 
likely to be disclosed to and this was statistically signif-
icant. (Table 2)
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Table 2 Child characteristics in the disclosed and non-disclosed groups 
Variable Disclosure status OR CI p-value 
 Yes  No    
 Number (%) Number (%)    
Sex      
Male 45 (41.8) 38 (50    ) 0.9 0.5-1.6 0.6 
Female 53 (58.2) 38 (50)    
Age   X2 37.4 df = 2 0.000* 
5-7 ψ 14 (14.3) 32 (42.1) 14.8 5.6-39.0  0.000* 
8-10 32 (32.7) 36 (47.4) 7.3 3.0-17 0.000* 
>10 52 (53.1) 8 (5) 1   
On ART      
Yes 63 (64.9) 36 ( 48.6) 1.9 1.0-3.6 0.03* 
No 34 (35.1) 38 (51.4)    
Duration on ART   X2 8.6  df 3 0.000 
0 months Ж 31 (33) 37 (52.9) 2.3 1.0-5.1 0.04 
0-12 months 19 (20.2) 14 (20.0) 1.4 0.6-3.7 0.04 
13-24 months 17 (18.7) 5 (5) 0.5 0.2-1.7 0.5 
>24 months 27 (28.7) 14 (20.1) 1  0.04* 
Ariel Club      
Yes 1 84 (85.7) 34 (44.7) 7.4 3.6-15.3  <0.001* 
No 2 14 (14.3) 42 (55.3)    
* Represents the significant factors 
X2 We used the Chi Square to analyse for statistical significancy 
> 10 years Ψ Is the reference category for age 
> months Ж is the reference category for ART 
Average age at disclosure to children was 9.22 years (s.d 3.0). 
Average duration from testing to disclosure was 1.1 years with a range of  zero to five years. 
 
Bivariate analysis was done for caretaker factors and in-
formation was collected about caretaker characteristics 
and this is presented in table 3.Those who had tested 
for HIV were 2.6 times more likely to disclose com-
pared to those who had not tested. This was significant-
ly associated with disclosure to the child as illustrated in 
table 4 above.  Relationship to the child, level of  edu-
cation of  the caretaker were not significantly associated 
with disclosure status of  the child (Table 3).       
Table 3 Caretaker characteristics in disclosed and non-disclosed groups 
Variable Disclosure    
 Yes N (%) No N (%) OR CI P value 
Relationship to child      
Biological parents      
Yes 66 (67.3) 51 (67.1) 1.1 0.5-1.9 0.97 
No 31 (32.7) 26(32.6)    
Highest Level of education      
0 (None + Primary) 84 (86.7) 65 (43.6) 1.2 0.5-2.8 0.684 
1 (Post primary) 13 (13.3) 12 (15.8)    
Occupation      
Salaried + Business 36 (37.5) 24 (32.9) 1.2  0.7-2.3 0.54 
Other 60 (62.5) 49 (67.1)    
Caretaker ever tested      
Yes 80 (81.6) 48 (63.2) 2.6 1.2-5.2 0.006* 
No 18 (18.4) 28 (36.8)    
Sex of caretaker      
1 Male 19 (19.4) 22 (28.9) 0.6 0.3-1.2 0.14 
2 Female 77 (80.6) 55 (71.1)    
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Multiple logistic regression of  factors associated 
with disclosure    
Multiple logistic regression was used to control for con-
founding. All risk factors that were found to be signifi-
cantly associated with disclosure of  HIV serostatus to 
children at bivariate analysis (p value < 0.05), and all 
plausible factors that were not significant during bivar-
iate analysis were put into logistic regression analysis 
(Table 4). Age of  the child, being a member of  the psy-
chosocial support group and caretaker having tested for 
HIV remained significantly associated with disclosure 
even on multivariate analysis. Being on ART was not 
significant on multivariate analysis. Each unit increase 
in the age of  the child increases the Odds of  being dis-
closed to by a factor of  1.5. Attendance at a psychoso-
cial support groups shows a positive relationship indi-
cating that the more a person attends the psychosocial 
support group the higher the likelihood that the child is 
disclosed to. 
Table 4: Adjusted Odds Ratios from multivariate analysis 














7.4 0.001 3.6-15.3 5.0 2.1-10.8 < 0.001* 
Age of the child X2 37.4  0.000 df=1 1.5 1.2-1.6 < 0.001* 
Caretaker having 
tested for HIV 
2.8 0.005 1.4-5.6 0.5 0.2-0.9 0.03* 
Whether patient is 
on ART or not. 
1.9 0.03 1.0-3.6 0.9 0.33-2.5 0.79 
 
Eighty seven percent of  the primary caretakers 87% 
(85/98) said that disclosing serostatus had helped the 
child to take drugs better, and about 10% (9/98) felt 
relieved for telling the truth. Like the caretakers, 85 
% (17/20) of  the children thought it was good to be 
disclosed to. All health workers (10/10) interviewed 
thought that the possible benefits of  disclosure were 
to improve adherence, positive living, improve quality 
of  life and build self  esteem and confidence among the 
HIV positive children. Problems encountered by care-
takers during the process of  disclosure included not 
knowing what to say 36 (40%), no problem 30 (34%), 
guilt of  transmission 6 (7%) and other problems 17 
(19%) included fear of  many questions from the chil-
dren, fear to hurt the child, not in position to handle the 
depression resulting from disclosure and thoughts of  
dying after disclosure.  
Health service factors
Ten health workers in the HIV clinic were interviewed 
and these included; three paediatricians, one medical of-
ficer, one clinical officer, four nurse counselors and one 
dispenser. They handle issues of  disclosure but without 
reference to any specific guidelines. Only five of  the 
health workers had training directly addressing issues 
of  disclosure in children and this was included in the 
counseling course for paediatric HIV.
The health workers said they were not aware of  guide-
lines for disclosure in children except for one who had 
seen those adopted locally for an institution. All health 
workers thought there was need for these guidelines at 
National level. All health workers thought that caretak-
ers should be supported during the process of  disclo-
sure especially in cases where the parents have failed to 
disclose. If  they completely fail, then the health worker 
should do the disclosure. 
Discussion
Mother to child transmission (MTCT) accounts for 
about 18% of  the new infections in Uganda. Standard 
antiretroviral therapy has lead to improved quality of  
life, reduced morbidity and mortality. Despite benefits 
of  disclosure, some caretakers do not disclose to chil-
dren their own HIV status. The study was designed to 
identify prevalence of  disclosure and factors affecting 
disclosure of  HIV sero status to children aged 5 to 18 
years attending Jinja Hospital Paediatric HIV clinic. We 
found disclosure rates in 56% of  the children. Among 
those not disclosed to, non-disclosure was 19% and 
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deception 25%. Factors associated with disclosure of  
sero-status to a child were age, being on antiretroviral 
therapy, attending psychosocial support group, and par-
ents/caretakers having tested for HIV.
  
The rates of  complete disclosure among HIV infect-
ed children aged 5 to 18 years in this study was 43.1% 
which is similar to that reported by Mialky et al27  in 
Philadelphia where the rate of  disclosure was 43%. This 
is possibly because the age groups studied were similar. 
However, the rate of  disclosure in this study is high-
er than 19.8% reported in Thailand by Boon-Yashidi 
et al.8 This could be because the age group he studied 
was younger. Secondly, the rates of  disclosure could be 
higher in this study because many of  the children are 
attending the psychosocial support groups where HIV 
is discussed.  
In this study, partial disclosure was about 12% and this 
is lower than that reported by Gortmarker et al.4  who 
reported partial disclosure as the most common with 
rates of  40%. This could be so because in our study, 
the children who were told lies about their diagnosis 
were categorized under non-disclosure.  Gortmarker et 
al reported that a similar pattern of  partial disclosure 
often occurred in conjunction with illness deception.4 
Partial disclosure may be considered as part of  the pro-
cess of  disclosure. Among children that were told lies 
about their illness, most of  the lies were about co-mor-
bid conditions, which seemed more acceptable and less 
stigmatizing. This is similar to a study reported by in 
which deception often entailed caregivers telling their 
children only about a co-morbid condition, and attrib-
uting all medical needs to that less-stigmatized condi-
tion.17
Average age at disclosure was about 9.2 years. This is 
similar to other studies8,27 where the mean age of  dis-
closure was 9.6 years and 9 years respectively.  This is 
probably because at this age, cognitive development of  
illness begins.28 The youngest age of  disclosure in this 
study was 5 years and this is in line with what some 
experts are advocating for, disclosure as early as 5 to 
7 years.25,29,30 However, in this study, most of  the care-
takers thought that younger children did not seem to 
understand the implications of  HIV diagnosis. Most of  
the children thought the optimal age for specific discus-
sions about an HIV infected child’s health should be 
conducted at an average age of  10 years. This is similar 
to the thoughts of  the care takers who suggested that 
specific discussions regarding HIV infection should be 
delayed to a median of  10 years.10 It is also in agree-
ment with the theory of  child’s cognitive understanding 
of  illness, which considers the age from 9 to 10 years 
and older as the best time for HIV infected children to 
know about their sickness as at this age children can un-
derstand about causes of  illness and its consequences.28
Attending the psycho social support group was sig-
nificantly associated with disclosure and this could be 
because caretakers share their experiences and lessons 
learnt, including passing of  information on HIV to 
children. This is similar to a study in Italy where family 
group psychotherapy had a positive impact on the envi-
ronment of  HIV-infected children, promoting psycho-
logical well-being and the disclosure of  the HIV status 
to children.31  Being on ART and duration on ART was 
significantly associated with disclosure. It is similar to a 
study by Menon et al.,32 in Zambia who reported that 
children on antiretroviral therapy were most likely dis-
closed to. However the findings in this study are differ-
ent from what was reported in Thailand where being 
on ART and duration on ART were not significantly 
associated with disclosure.33 This could be explained 
by the counseling that is done prior to starting ART in 
which the caretakers are given information and encour-
aged to disclose hence empowering the caretaker with 
knowledge to discuss with the child. Caretaker having 
tested him/herself  was associated with disclosure. This 
is related to studies by Mellins et al., Weiner et al. and 
Ledlie.9,13,34 which showed that those caretakers who 
were HIV negative were likely to disclose. This is possi-
bly because of  the pre and post test counseling that the 
caretaker could have received when he/she had her own-
test.                                                                                                                         
The investigators found that most of  the caretakers 
(90%), children (85%) and all health workers thought 
that disclosure had improved adherence. Paediatric 
HIV providers believe that disclosure is important for 
helping children understand the need for ART and cre-
ate trusting relationships that facilitate adherence,6,35 In 
Mildmay Centre Uganda, complete disclosure of  HIV 
status by caregivers to children and strong parental re-
lationships were related to good adherence.6 In Brazil, 
Marques et al. 2006 found that despite its initial negative 
impact, disclosure resulted in improved healthcare and 
better dialogue among the adolescents, caregivers, and 
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healthcare providers.7 This could also be explained by 
the fact that when a child knows the reason why he/she 
is taking the medication, he is likely to co-operate. 
Only half  of  the health workers had been trained in dis-
closure to children and there were no guidelines to refer 
to. This is similar to the situation in Thailand where 
there were no guidelines for disclosure.36 The conse-
quences of  not having guidelines are that healthcare 
providers would approach disclosure issues differently 
with uncertainty. In this study, health workers thought 
that the health workers role was to support the disclo-
sure process. This is similar to a study conducted by 
Myer et al. 2006 in South Africa. 
Conclusions: The overall prevalence of  disclosure was 
low. Parents and health workers should be adequately 
empowered to deal with the process of  disclosure. Es-
tablishing psychosocial support groups, adequate coun-
seling for the care takers, training health workers and 
developing/disseminating culturally appropriate and 
age-specific guidelines on disclosure of  serostatus to 
children would help deal with the difficult process of  
disclosure. 
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